The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer
Abstract
Purpose: Preoperative chemoradiotherapy is considered standard treatment for locally advanced rectal cancer, although the scientific evidence for the chemotherapy addition is limited. This trial investigated whether chemotherapy as part of a multidisciplinary treatment approach would improve downstaging, survival, and relapse rate. Patients and Methods: The randomized study included 207 patients with locally nonresectable T4 primary rectal carcinoma or local recurrence from rectal carcinoma in the period 1996 to 2003. The patients received either chemotherapy (fluorouracil/leucovorin) administered concurrently with radiotherapy (50 Gy) and adjuvant for 16 weeks after surgery (CRT group, n = 98) or radiotherapy alone (50 Gy; RT group, n = 109). Results: The two groups were well balanced according to pretreatment characteristics. An R0 resection was performed in 82 patients (84%) in the CRT group and in 74 patients (68%) in the RT group (P = .009). Pathologic complete response was seen in 16% and 7%, respectively. After an R0 + R1 resection, local recurrence was found in 5% and 7%, and distant metastases in 26% and 39%, respectively. Local control (82% v 67% at 5 years; log-rank P = .03), time to treatment failure (63% v 44%; P = .003), cancer-specific survival (72% v 55%; P = .02), and overall survival (66% v 53%; P = .09) all favored the CRT group. Grade 3 or 4 toxicity, mainly GI, was seen in 28 (29%) of 98 and six (6%) of 109, respectively (P = .001). There was no difference in late toxicity. Conclusion: CRT improved local control, time to treatment failure, and cancer-specific survival compared with RT alone in patients with nonresectable rectal cancer. The treatments were well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Bosset, J.-F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., & Ollier, J.-C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060829 · Cited by 2,688
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Gérard, J.-P., Conroy, T., Bonnetain, F., Bouché, O., Chapet, O., Closon-Dejardin, M.-T., Untereiner, M., Leduc, B., Francois, É., Maurel, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7629 · Cited by 1,731 · cited 1×
“The generally high quality of the surgery can be one explanation why the outcome in this trial (predominantly cT4) was not much worse than in the two parallel trials (predominantly cT3).(4,5) The quality of the pathologic examination in LARCS, performed in routine care, was not sufficient according to standards discus…”
ResultPathological features of rectal cancer after preoperative radiochemotherapy
Dworak, O., Keilholz, L., & Hoffmann, A. (1997) · International Journal of Colorectal Disease · doi:10.1007/s003840050072 · Cited by 1,338
Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bebenek, M., & Kryj, M. (2006) · British Journal of Surgery · doi:10.1002/bjs.5506 · Cited by 1,244
Self-citationProlongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma
Gastrointestinal Tumor Study Group (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122301 · Cited by 1,130
(2001) · The Lancet · doi:10.1016/s0140-6736(01)06409-1 · Cited by 870
Chau, I., Brown, G., Cunningham, D., Tait, D., Wotherspoon, A., Norman, A. R., Tebbutt, N., Hill, M., Ross, P. J., Massey, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4875 · Cited by 474
Collette, L., Bosset, J.-F., den Dulk, M., Nguyen, F., Mineur, L., Maingon, P., Radosevic-Jelic, L., Piérart, M., & Calais, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9685 · Cited by 447
A Systematic Overview of Radiation Therapy Effects in Rectal Cancer
Glimelius, B., Grönberg, H., Järhult, J., Wallgren, A., & Cavallin-ståhl, E. (2003) · Acta Oncologica · doi:10.1080/02841860310012301 · Cited by 263
Self-citationMulticenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer
Rödel, C., Liersch, T., Hermann, R. M., Arnold, D., Reese, T., Hipp, M., Fürst, A., Schwella, N., Bieker, M., Hellmich, G., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3675 · Cited by 230
Tveit, K. M., Guldvog, I., Hagen, S., Trondsen, E., Harbitz, T., Nygaard, K., Nilsen, J. B., Wist, E., & On behalf of the Norwegian adjuvant Rectal Cancer Project Group (1997) · British Journal of Surgery · doi:10.1002/bjs.1800840827 · Cited by 229
Self-citationKapiteijn, E., Marijnen, C. A. M., Colenbrander, A. C., Klein Kranenbarg, E., Steup, W. H., van Krieken, J. H. J. M., van Houwelingen, J. C., Leer, J. W. H., & van de Velde, C. J. H. (1998) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/s0748-7983(98)93500-4 · Cited by 178
Mohiuddin, M., Hayne, M., Regine, W. F., Hanna, N., Hagihara, P. F., McGrath, P., & Marks, G. M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00732-x · Cited by 170
Frykholm, G. J., Påhlman, L., & Glimelius, B. L. G. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01479-1 · Cited by 128
Self-citationThe ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers
Blomqvist, L., & Glimelius, B. L. G. (2007) · Acta Oncologica · doi:10.1080/02841860701802585 · Cited by 123
Self-citationTveit, K. M., Guldvog, I., Hagen, S., et al. (1997) · PubMed · Cited by 121
Self-citationBujko, K., Kępka, L., Michalski, W., & Nowacki, M. P. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.04.012 · Cited by 109
Self-citationSebag‐Montefiore, D., Glynne‐Jones, R., Falk, S., Meadows, H. M., & Maughan, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602818 · Cited by 93
Glynne‐Jones, R., Falk, S., Maughan, T., Meadows, H. M., & Sebag‐Montefiore, D. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603570 · Cited by 55
Glynne‐Jones, R., & Anyamene, N. A. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.05.047 · Cited by 42
Pre-operative imaging of rectal cancer and its impact on surgical performance and treatment outcome
Beets‐Tan, R. G. H., Lettinga, T., & Beets, G. L. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.02.015 · Cited by 37
Rectal cancer irradiation. Long course, short course or something else?
Glimelius, B. L. G. (2006) · Acta Oncologica · doi:10.1080/02841860601019413 · Cited by 34
Self-citationOperative Treatment of Locally Recurrent Rectal Cancer
Wiig, J. N., Larsen, S. G., & Giercksky, K.-E. (2005) · Springer eBooks · doi:10.1007/3-540-27449-9_15 · Cited by 32
Self-citationEmerging therapies for rectal cancer
Chua, Y. J., & Cunningham, D. (2006) · Colorectal Disease · doi:10.1111/j.1463-1318.2006.01065.x · Cited by 8
Cited by
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Glynne-Jones, R., Wyrwicz, L., Tiret, E., Brown, G., Rödel, C., Cervantes, A., & Arnold, D. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx224 · Cited by 2,046
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Glimelius, B., Tiret, E., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt240 · Cited by 1,783
Self-citationBahadoer, R. R., Dijkstra, E. A., van Etten, B., Marijnen, C. A. M., Putter, H., Kranenbarg, E. M.-K., Roodvoets, A. G. H., Nagtegaal, I. D., Beets-Tan, R. G. H., Blomqvist, L. K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30555-6 · Cited by 1,693
Self-citationSchmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Self-citationRödel, C., Graeven, U., Fietkau, R., Hohenberger, W., Hothorn, T., Arnold, D., Hofheinz, R.-D., Ghadimi, M., Wolff, H. A., Lang-Welzenbach, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00159-x · Cited by 726
Metadata
- Authors
- Brændengen, M., Tveit, K. M., Berglund, Å., Birkemeyer, E., Frykholm, G., Påhlman, L., Wiig, J. N., Byström, P., Bujko, K., & Glimelius, B.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-08-01
- Volume
- 26
- Issue
- 22
- Pages
- 3687-3694
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2171573992
- Cited by
- 476
- References
- 26
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.